MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 18.04.2026
QIAGEN N.V. DSO 2011-2026 | QGEN
DSO Jährlich QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 30.8 | 74.7 | 88.1 | 82.7 | 78.2 | 89.5 | 92.9 | 86.5 | 93.7 | 89.4 | 77.9 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 93.7 | 30.8 | 80.4 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Co-Diagnostics
CODX
|
94.7 | $ 1.29 | -21.17 % | $ 1.72 M |  USA |
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 15.7 | -3.03 % | $ 475 M | USA |
 |
Agilent Technologies
A
|
63.8 | $ 111.7 | -1.38 % | $ 34 B | USA |
 |
Castle Biosciences
CSTL
|
50.2 | $ 19.13 | 1.32 % | $ 555 M | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 142.54 | -0.49 % | $ 22.7 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
66.9 | $ 1.76 | -2.22 % | $ 7.79 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 19.97 | -2.54 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
Lantheus Holdings
LNTH
|
80.5 | $ 93.91 | -2.86 % | $ 6.34 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 031.64 | -0.99 % | $ 21.3 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
52.3 | $ 3.58 | -1.1 % | $ 332 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 415.27 | -0.93 % | $ 12 B | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M |  China |
 |
NeoGenomics
NEO
|
77.7 | $ 8.24 | -1.44 % | $ 1.06 B | USA |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 18.62 | -1.64 % | $ 417 M | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 150.85 | -5.2 % | $ 7.48 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
Natera
NTRA
|
81.5 | $ 186.36 | -5.36 % | $ 18.3 B | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | USA |
 |
Senseonics Holdings
SENS
|
1.04 | $ 5.77 | -0.86 % | $ 241 M | USA |
 |
Guardant Health
GH
|
46.1 | $ 94.92 | -3.79 % | $ 11.9 B | USA |
 |
Personalis
PSNL
|
63.8 | $ 6.36 | -5.22 % | $ 568 M | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 116.38 | -0.61 % | $ 9.6 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
27 | $ 53.01 | 0.04 % | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.34 | -2.9 % | $ 5.38 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 250.4 | -1.43 % | $ 20.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 438.34 | -2.2 % | $ 165 B | USA |
 |
Trinity Biotech plc
TRIB
|
87.2 | $ 0.57 | -1.59 % | $ 205 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K |  Israel |
 |
Twist Bioscience Corporation
TWST
|
44.5 | $ 49.17 | -7.14 % | $ 2.94 B | USA |
 |
Waters Corporation
WAT
|
306 | $ 329.22 | -1.2 % | $ 19.6 B | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 8.19 | -2.85 % | $ 1.78 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 186.61 | -0.71 % | $ 20.7 B | USA |